AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2024
Sep 10, 2024
30786_dirs_2024-09-10_de14f43a-b0c5-454d-b24f-89bfb576301f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2024-09-06
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman & CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-06 | Restricted Stock Units | $0 | A | 13822 | Acquired | Bio-Rad A Common Stock (13822) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 438238 | Direct |
| Bio-Rad B Common Stock | 361466 | Direct |
| Bio-Rad B Common Stock | 13006 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these shares.
F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.